Oncology Drugs Market Research Report, Growth & Forecast

This study covers the world outlook for premetrexed and combinations for malignant mesothelioma across more than 190 countries. For each year reported, estimates are given for the latent demand, or po...

The Global Ovarian Cancer Drugs Market will grow from USD 4.32 Billion in 2025 to USD 6.36 Billion by 2031 at a 6.66% CAGR. Ovarian cancer drugs encompass a diverse range of pharmacological interventi...

HNY Research projects that the Pertuzumab market size will grow from 283.56 Million USD in 2025 to 417.13 Million USD by 2031, at an estimated CAGR of 6.64%. The base year considered for the study is...

HNY Research projects that the Recombinant Human Endostatin market size will grow from 162.61 Million USD in 2025 to 277.01 Million USD by 2031, at an estimated CAGR of 9.28%. The base year considered...

According to our (Global Info Research) latest study, the global Anticancer Drugs market size was valued at US$ 233550 million in 2025 and is forecast to a readjusted size of US$ 480980 million by 203...

HNY Research projects that the Follicular Lymphoma Treatment market size will grow from 1871.28 Million USD in 2025 to 2373.83 Million USD by 2031, at an estimated CAGR of 4.04%. The base year conside...

HNY Research projects that the Oncology Injection Drug market size will grow from 186.29 Million USD in 2025 to 274.86 Million USD by 2031, at an estimated CAGR of 6.7%. The base year considered for t...

HNY Research projects that the Recurrent Glioblastoma Multiforme Treatment market size will grow from 529.86 Million USD in 2025 to 787.64 Million USD by 2031, at an estimated CAGR of 6.83%. The base...

The global Checkpoint Inhibitors for Treating Cancer market size is expected to reach $ 116680 million by 2032, rising at a market growth of 25.0% CAGR during the forecast period (2026-2032). Checkpoi...

The global Chemotherapy Infusion Pumps market size is expected to reach $ 391 million by 2032, rising at a market growth of 6.6% CAGR during the forecast period (2026-2032). Chemotherapy pumps are one...

The global Intravesical Bacillus Calmette market size is expected to reach $ 614 million by 2032, rising at a market growth of 8.0% CAGR during the forecast period (2026-2032). Intravesical Bacillus C...

The global Medical Asparaginase market size is expected to reach $ 440 million by 2032, rising at a market growth of 1.5% CAGR during the forecast period (2026-2032). Asparaginase is an enzyme, as a m...

The global Peptide Cancer Vaccine market size is expected to reach $ million by 2032, rising at a market growth of 19.3% CAGR during the forecast period (2026-2032). Peptide cancer vaccines are innova...

The global Radiation Therapy Equipment market size is expected to reach $ 4864 million by 2032, rising at a market growth of 7.2% CAGR during the forecast period (2026-2032). Radiotherapy has two dist...

The global Topotecan Hydrochloride market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Topotecan Hydrochloride is the hydroch...

The global Tyrosine Kinase JAK Inhibitors market size is expected to reach $ 113500 million by 2032, rising at a market growth of 2.1% CAGR during the forecast period (2026-2032). Tyrosine kinase JAK...

The global Anticancer Drugs market size is expected to reach $ 480980 million by 2032, rising at a market growth of 11.0% CAGR during the forecast period (2026-2032). Anticancer drugs are medications...

The global Paclitaxel market size is expected to reach $ 259 million by 2032, rising at a market growth of 8.0% CAGR during the forecast period (2026-2032). Paclitaxel is a mitotic inhibitor used in C...

The Liposarcoma Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...

The brain tumor drugs market, growing at a 7.36% CAGR, is anticipated to reach USD 4.276 billion in 2031 from USD 2.792 billion in 2025. The brain tumor drugs market is a critical and high-stakes segm...

Findings & Highlights: Global Claudin18.2 Targeted Therapy Market Opportunity: > US$ 800 Million By 2030Number Of Approved Claudin18.2 Targeted Therapy: 1Approved Claudin18.2 Targeted Therapy Dosage,...

Findings & Highlights: First MYC Targeting Therapy Approval Expected By 2030Global MYC Targeting Therapies Market Opportunity OutlookComprehensive Insight On MYC Targeting Therapies In Clinical Trial...

Findings & Highlights: Global & Regional Market Trends InsightNumber Of Approved EZH2 Targeted Therapies: 2 TherapiesConditional Approval To EZH2 Therapy: 1 TherapyApproved Therapy Dosage, Price & Sa...

: The global market for oncology biosimilars is estimated to grow from $9.6 billion in 2025 and projected to reach $17.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6%...

The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, according to a new ... number of approvals for new immunotherapeutic drugs is driving the global market. Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical ...

The Intratumoral Cancer Therapies Market was valued at US$ 219.79 million in 2023 and is anticipated to reach US$ 630.7 million by 2033, at a CAGR of 0.11 from 2026 to 2032. The report delivers in-dep...

The Checkpoint Inhibitor Refractory Cancer Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...

The Follicular Thyroid Cancer Drug Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...

The Gall Bladder Cancer Treatment Market was valued at USD 79.5 million in 2022 and is anticipated to reach by , at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth insights into key ma...

The Kidney Cancer and Renal Cell Carcinoma Drugs Market was valued at USD 5.6 billion in 2022 and is anticipated to reach by , at a CAGR of 0.063 from 2026 to 2032. The report delivers in-depth insigh...

The Oral Cancer Treatment Market was valued at USD 1.9 billion in 2022 and is anticipated to reach by , at a CAGR of 0.051 from 2026 to 2032. The report delivers in-depth insights into key market dyna...

The Papillary Thyroid Carcinoma Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.047 from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...

The PD1/PDL1 Inhibitors – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The rep...

The Radiation Toxicity Treatment Market was valued at US$ 2.9 billion in 2022 and is anticipated to reach US$ 4.6 billion by 2030, at a CAGR of 0.061 from 2026 to 2032. The report delivers in-depth in...

The Salivary Gland Cancer Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...

The Tonsil Cancer Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.046 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...

The Urinary Tract Cancer Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.184 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...

... , radiation therapy, chemotherapy, and immunotherapy in the head and neck cancer therapeutics market. Major challenges faced by this patient population ... drug delivery approaches to improve overall survival rates Among EU5, Germany captured the top position in the global head and neck cancer therapeutics ...

The HER2+ Gastric Cancer Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

The global Keytruda market size was estimated at USD 31.38 billion in 2025 and is projected to reach USD 24.95 billion by 2033, declining at a CAGR of -3.80% from 2026 to 2033. The market outlook for...

The Ovarian Cancer Drugs Market was valued at US$ 3.81 billion in 2024 and is anticipated to reach US$ 6.72 billion by 2033, at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth insights...

The Prostate Cancer Drugs Market was valued at US$ 13.22 Billion in 2024 and is anticipated to reach US$ 28.10 Billion by 2033, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insig...

The US & EU Melanoma Therapeutics Market was valued at US$ 3.89 billion in 2024 and is anticipated to reach US$ 8.99 billion by 2033, at a CAGR of 0.098 from 2026 to 2032. The report delivers in-depth...

The global interventional oncology market size was estimated at USD 2.90 billion in 2025 and is projected to reach USD 5.61 billion by 2033, growing at a CAGR of 8.59% from 2026 to 2033. This growth...

The Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, valued at USD 14.38 Billion in 2024, is projected to experience a CAGR of 3.65% to reach USD 17.83 Billion by 2030. Anti-vascula...

The Global Chronic Lymphocytic Leukemia Treatment Market will grow from USD 13.37 Billion in 2024 to USD 21.51 Billion by 2030 at a 8.25% CAGR. The global chronic lymphocytic leukemia (CLL) treatment...

The Global Melanoma Drugs Market will grow from USD 7.42 Billion in 2024 to USD 11.98 Billion by 2030 at a 8.31% CAGR. Melanoma drugs refer to pharmaceutical agents developed to treat melanoma, an agg...

The Global Myeloproliferative Disorders Drugs Market will grow from USD 9.94 Billion in 2024 to USD 14.06 Billion by 2030 at a 5.95% CAGR. Myeloproliferative Disorders (MPDs) drugs comprise a speciali...

The Global Tyrosine Kinase Inhibitors Market will grow from USD 52.07 Billion in 2024 to USD 83.09 Billion by 2030 at a 8.10% CAGR. Tyrosine Kinase Inhibitors, or TKIs, are a class of pharmaceutical d...

The Global Angiosarcoma Treatment Market , valued at USD 280.11 Million in 2024, is projected to experience a CAGR of 6.11% to reach USD 399.85 Million by 2030. Angiosarcoma treatment encompasses a ra...